Therapeutic Vaccines Market 2019-2023:Global Market Size & Industry Analysis

Posted by sarahbennu on September 9th, 2019

Global therapeutic vaccines market size is forecast to grow by USD 978 million during 2019-2023 at a CAGR of 19% with cancer vaccines segment having the largest market share. Therapeutic vaccine market analysis indicates growth will be driven by the rising incidence and prevalence of diseases. Therapeutic vaccines industry growth will also be impacted by the increase in R&D activities related to novel therapeutic vaccines. A key factor driving the growth of the global therapeutic vaccines market is the rising incidence and prevalence of diseases. Several diseases including HIV, cancer, chronic diseases, and human papillomavirus are spreading at an alarming rate. In addition, there has been an increase in the prevalence of chronic diseases including asthma, diabetes, Alzheimer’s, multiple sclerosis, and chronic obstructive pulmonary diseases in the recent years. The rising incidence of these diseases has created significant opportunities for the growth of the therapeutic vaccines market.

Looking for more information on this market? Request a free sample report http://bit.ly/2lLKHiQ

As per Technavio, the increase in R&D activities related to novel therapeutic vaccines will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global therapeutic vaccines market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

Global therapeutic vaccines market: Increase in R&D activities related to novel therapeutic vaccines

There has been a continuous increase in R&D activities related to development of novel therapeutic vaccines. Several diseases including hepatitis B virus infections, Alzheimer’s disease, and cancer are becoming a major public health concern across the world. This has led to the need to develop innovative therapeutic vaccines for these diseases including chronic hepatitis B. For instance, researchers have developed a new-generation vaccine known as NASVAC for chronic hepatitis B by using a novel immunization route and a novel antigen called HBcAg. Therefore, rising investments in R&D activities will boost the growth of the global therapeutic vaccines market in the forthcoming years.

Global therapeutic vaccines market: Segmentation analysis

This market research report segments the global therapeutic vaccines market by type (cancer vaccines, infectious diseases vaccines, neurological diseases vaccines, autoimmune diseases vaccines, and other diseases vaccines) and geographic regions (North America, Europe, Asia, and ROW).

North America led the market in 2018, followed by Europe, Asia, and ROW respectively. The market growth in North America can be attributed to the presence of various infectious, neurological, and autoimmune diseases. The growing prevalence of several diseases is further encouraging researchers to develop novel treatment therapies for these diseases, which will contribute to the market dominance of North America.

Some of the key topics covered in the report include:

Market Landscape

• Market ecosystem
• Market characteristics
• Market segmentation analysis

Market Sizing

• Market definition
• Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

• Regional comparison
• Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

• Vendors covered
• Vendor classification
• Market positioning of vendors
• Competitive scenario